Skip to content
Logo
  • Home
  • About us
    • WHAT IS CLLAN?
    • WHY IS CLLAN IMPORTANT?
    • CLLAN Objectives
    • Leadership
    • Sponsors
  • Contact
  • Newsletter
  • CLL Information
  • Membership
    • Membership
    • Members
    • Tribute
  • Initiatives
    • *NEW*

      CLL HORIZONS 2025
    • CLL IC TASKFORCE
      • About us
      • Become an industry partner
    • CLL IMMUNE CHALLENGES WHITE PAPER
    • *NEW*

      BTKi: A Patient Information Guide
    • *NEW*

      2023 GLOBAL SURVEY INSIGHTS
    • Leukemia Carer Experience Survey
    • Leukemia patient experience survey
    • Survey Comparison Report
    • CLL Advocacy Survey
    • World CLL Day
    • ICBCC
    • Workshops and webinars
    • Blood Cancer Patient Advocates Academy
  • CLLAN TOOLS
    • *NEW*

      CLL Clinical Trials Hub
    • RESOURCE HUB
    • ADVOCACY TOOLKIT
  • COVID-19 resources
    • Statement
  • News & Events
    • News & Events
    • Newsletter

Sitemap

  • CLL Horizons 2024
  • CLL Horizons 2025
  • CLL IC Taskforce
    • Become an industry partner
  • Webinar on “Latest advances in the treatment of acute lymphoblastic leukemia (ALL) – What does this mean for patients?”
  • Webinar on “Latest advances in the treatment of chronic myeloid leukemia (CML) – What does this mean for patients?”
  • Webinar on “Latest advances in the treatment of chronic lymphocytic leukemia (CLL) – What does this mean for patients?”
  • Webinar on “Latest advances in the treatment of acute myeloid leukemia (AML) – What does this mean for patients?”
  • CLLAN webinar – How are advances in Bruton’s tyrosine kinase targeted therapies continuing to change how chronic lymphocytic leukemia (CLL) is treated?
  • CLLAN webinar on CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs
  • Latest updates on CLL and what this means for you
  • LePAF
  • Home
  • CLL Horizons 2021
  • World CLL Day
  • “How to sustainably build and develop a patient group”
  • COVID-19 vaccination and immune challenges for leukemia
  • Developing collaboration between patient groups and clinical groups – working together to improve patient outcomes
  • CLL Fast Facts
  • CLL immune challenges and white paper
  • Newsletter
  • COVID-19 resources
    • ICBCC
    • CLL Advocates Network Statement
  • Membership
    • Tribute
    • Members
    • Join us
  • About us
  • About
    • Leadership
  • Sponsors
  • Initiatives
  • Contact
  • CLL Information
  • News & Events
  • Sitemap
  • Cookies
  • Privacy
  • Terms & Conditions
Let's connect on social

Sign up to our CLLAN Newsletter

    • Terms & Conditions
    • Privacy
    • Cookies
    • Sitemap
    © 2025 - CLL Advocates Network

    CLL Advocates Network is formally hosted by the Leukemia Patient Advocates Foundation (Stiftung Leukämiepatientenvertreter), Chamber of Commerce of the Canton Bern: CH-036.7.052.001-2.

    Leukemia Patient Advocates Foundation
    P.O.B. 453, CH-3000 Bern 7, Switzerland

    Brandcast Health
    • CLL Information
    • Membership
      • Membership
      • Members
      • Tribute
    • Initiatives
      • *NEW*

        CLL HORIZONS 2025
      • CLL IC TASKFORCE
        • About us
        • Become an industry partner
      • CLL IMMUNE CHALLENGES WHITE PAPER
      • *NEW*

        BTKi: A Patient Information Guide
      • *NEW*

        2023 GLOBAL SURVEY INSIGHTS
      • Leukemia Carer Experience Survey
      • Leukemia patient experience survey
      • Survey Comparison Report
      • CLL Advocacy Survey
      • World CLL Day
      • ICBCC
      • Workshops and webinars
      • Blood Cancer Patient Advocates Academy
    • CLLAN TOOLS
      • *NEW*

        CLL Clinical Trials Hub
      • RESOURCE HUB
      • ADVOCACY TOOLKIT
    • COVID-19 resources
      • Statement
    • News & Events
      • News & Events
      • Newsletter